Skip to main content
. 2021 Dec 9;59:100794. doi: 10.1016/j.drup.2021.100794

Fig. 4.

Fig. 4

The viral cycle of SARS-CoV-2 and the Remdesivir target. Remdesivir is an inhibitor of the RNA-replicase (RdRp), therefore inhibition of this enzyme impairs the replication of the viral genome and hence, blocks the life cycle of the whole virus, or renders it defective.